A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects
Clinical trial NCT05480475 · COMPLETED
Trial details
- NCT number
- NCT05480475
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-03
- Primary completion
- 2022-09-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.